RZV Vaccine (Shingrix ®) Clinical Trials in Pavia, Lombarda

Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zoster in Vulnerable Population Receiving ImmunOmodulaNt Therapies